Physical Rehabilitation Program for Cardiorespiratory Health and Quality of Life Among Breast Cancer Survivors in UAE.
Launched by GULF MEDICAL UNIVERSITY · Aug 22, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a physical rehabilitation program can help improve heart health and overall quality of life for women who have survived breast cancer in the United Arab Emirates. The program lasts for two months and is designed specifically for women aged 18 to 65 who have completed chemotherapy and surgery (mastectomy) and are ready for physical rehabilitation. The goal is to see if this program can increase their cardiovascular endurance, which is their heart and lung fitness, and enhance their daily well-being.
To join the trial, participants must be women who have been diagnosed with early-stage breast cancer (stages I to IIIa) and are cleared by their doctors to start rehabilitation. However, women who have other serious health issues, like heart or lung diseases, or those still undergoing cancer treatment, cannot participate. During the trial, participants can expect to engage in a structured exercise program tailored to their needs and monitored for safety. This is a great opportunity for eligible women to potentially improve their health and quality of life after battling breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients suffering from breast cancer who have undergone Chemotherapy, Mastectomy, and cleared for post-surgical physical rehabilitation.
- • Age group -18 years to 65 years
- • Female patients only (gender predisposition)
- • Diagnosed with stage I-stage IIIa breast cancer. (As other stages of cancer include metastasis).
- Exclusion Criteria:
- • Patients diagnosed with prior cardiorespiratory disorders, cognitive dysfunction, and other health problems that would prevent safe participation.
- • Active breast cancer patients.
- • Participants who engaged in physical activity like the intervention group in any form.
About Gulf Medical University
Gulf Medical University (GMU) is a prestigious academic institution located in the United Arab Emirates, dedicated to advancing healthcare through innovative education and research. As a leading clinical trial sponsor, GMU focuses on enhancing medical knowledge and improving patient outcomes by conducting rigorous and ethically sound clinical studies. The university fosters collaborations with local and international healthcare organizations, ensuring adherence to the highest standards of clinical research. With a commitment to excellence in medical education and research, GMU plays a pivotal role in the development and evaluation of new therapeutic interventions and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Al Jurf, Ajman, United Arab Emirates
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported